Therapeutic Effect of Eugenol-Loaded Chitosan Nanoparticles Against Helicobacter pylori Infection: A Histologic and
Mohammad Javad Tahmasebi1, Mahmoud Osanloo2, Alireaza Tavassoli3
1Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran, fums.ac.ir.
Background:
Eugenol is a phenolic compound known for its antimicrobial, antifungal, and antioxidant properties. Its encapsulation in chitosan nanoparticles (EuChiNPs) enhances stability and therapeutic efficacy.
Objectives:
This study aimed to investigate the effects of EuChiNPs on Helicobacter pylori (H. pylori) infection in rats, focusing on its impact on inflammatory and apoptotic pathways.
Methods:
EuChiNPs were synthesized and characterized using DLS, TEM, and FTIR techniques. A total of 42 male Wistar rats were divided into six groups, including controls, H. pylori-infected, and treatment groups receiving EuChiNPs, standard antibiotics, or a combination. The effects of treatments were evaluated using RT-PCR, ELISA, Western blotting, and histopathology.
Results:
The combination of EuChiNPs and standard antibiotics significantly reduced the expression of inflammatory markers interleukin-1 beta (IL-1β) and interleukin-8 (IL-8). Serum levels of IL-1β, IL-8, and TNF-α were markedly decreased in the combination group compared with antibiotics alone (p < 0.0001). Western blot analysis revealed a reduction in caspase-3 and caspase-7 expression, indicating attenuation of apoptosis. Histopathological analysis showed improved mucosal integrity and reduced bacterial density in the combination treatment group.
Conclusion:
EuChiNPs demonstrated strong anti-inflammatory and antiapoptotic effects, especially when combined with standard antibiotics. This novel approach promises to improve H. pylori eradication while minimizing antibiotic resistance and side effects. Further clinical studies are recommended to validate these findings.
More Related Videos
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
06:42Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
01:27Peptic Ulcer
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...